Medicines with new active substances recommended for marketing authorisation
Number of medicines containing a new active substance not previously authorised recommended for marketing authorisation.
Unit Count Industry Pharmaceuticals
The chart
The figure
One published observation so far. A chart follows as soon as a second period is published.
Medicines with new active substances recommended for marketing authorisation
European Union, 2022
Every record
All records
1 record · 1 region · 2022
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Human medicines: highlights of 2022 | EMA | — | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Medicines with new active substances recommended for marketing authorisation. Retrieved from https://statorigin.org/indicators/medicines-with-new-active-substances-recommended-for-marketing-authorisation